Evidence map›Paper›PMID 36036558›Full record

ArticleBrain : a journal of neurology2023

Conserved patterns across ion channels correlate with variant pathogenicity and clinical phenotypes.

Tobias Brünger, Eduardo Pérez-Palma, Ludovica Montanucci, Michael Nothnagel, Rikke S Møller, Stephanie Schorge, Sameer Zuberi, Joseph Symonds, Johannes R Lemke, Andreas Brunklaus and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Identification of novel functional sites in the CaProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Plural molecular and cellular mechanisms of pore domainbioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 5 countries.

Tobias BrüngerCologne Center for Genomics, University of Cologne, 50931 Cologne, Germany.
Eduardo Pérez-PalmaCentro de Genética y Genómica, Facultad de Medicina Clínica Alemana, Universidad de Desarrollo, Santiago 7590943, Chile.ORCID 0000-0003-0546-5141
Ludovica MontanucciLerner Research Institute Cleveland Clinic, Genomic Medicine Institute, Cleveland, OH 44195, USA.
Michael NothnagelCologne Center for Genomics, University of Cologne, 50931 Cologne, Germany.
Rikke S MøllerDepartment of Epilepsy Genetics and Personalized Treatment, the Danish Epilepsy Center, DK 4293 Dianalund, Denmark.
Stephanie SchorgeDepartment of Neuroscience, Physiology and Pharmacology, UCL, London WC1E 6BT, UK.
Sameer ZuberiThe Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.ORCID 0000-0002-4489-4697
Joseph SymondsThe Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.ORCID 0000-0002-2141-4216
Johannes R LemkeInstitute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.ORCID 0000-0002-4435-6610
Andreas BrunklausThe Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.ORCID 0000-0002-7728-6903
Stephen F TraynelisDepartment of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, GA 30322-3090, USA.
Patrick MayLuxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4362 Esch-sur-Alzette, Luxembourg.ORCID 0000-0001-8698-3770
Dennis LalCologne Center for Genomics, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0002-5173-9636
Royal Hospital for Children · GBUniversity of Cologne · DEBroad Institute · USCleveland Clinic Lerner College of Medicine · USEmory University · USLeipzig University · DEUniversidad del Desarrollo · CLUniversity College London · GBUniversity of Luxembourg · LU

Funding

Project 3 - Development and investigation of murine models of channelopathy-associated epilepsyU54NS108874 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEORGE, ALFRED L. · 2018 to 2022
$12.1M
Glutamate receptors and human neurological diseaseR35NS111619 · NINDS · EMORY UNIVERSITY · PI Stephen F Traynelis · 2019 to 2026
$6.6M
NINDS NIH HHS R35 NS111619NINDS NIH HHS U54 NS108874
6 · The paper itself

Abstract

Clinically identified genetic variants in ion channels can be benign or cause disease by increasing or decreasing the protein function. As a consequence, therapeutic decision-making is challenging without molecular testing of each variant. Our biophysical knowledge of ion-channel structures and function is just emerging, and it is currently not well understood which amino acid residues cause disease when mutated. We sought to systematically identify biological properties associated with variant pathogenicity across all major voltage and ligand-gated ion-channel families. We collected and curated 3049 pathogenic variants from hundreds of neurodevelopmental and other disorders and 12 546 population variants for 30 ion channel or channel subunits for which a high-quality protein structure was available. Using a wide range of bioinformatics approaches, we computed 163 structural features and tested them for pathogenic variant enrichment. We developed a novel 3D spatial distance scoring approach that enables comparisons of pathogenic and population variant distribution across protein structures. We discovered and independently replicated that several pore residue properties and proximity to the pore axis were most significantly enriched for pathogenic variants compared to population variants. Using our 3D scoring approach, we showed that the strongest pathogenic variant enrichment was observed for pore-lining residues and alpha-helix residues within 5Å distance from the pore axis centre and not involved in gating. Within the subset of residues located at the pore, the hydrophobicity of the pore was the feature most strongly associated with variant pathogenicity. We also found an association between the identified properties and both clinical phenotypes and functional in vitro assays for voltage-gated sodium channels (SCN1A, SCN2A, SCN8A) and N-methyl-D-aspartate receptor (GRIN1, GRIN2A, GRIN2B) encoding genes. In an independent expert-curated dataset of 1422 neurodevelopmental disorder pathogenic patient variants and 679 electrophysiological experiments, we show that pore axis distance is associated with seizure age of onset and cognitive performance as well as differential gain versus loss-of-channel function. In summary, we identified biological properties associated with ion-channel malfunction and show that these are correlated with in vitro functional readouts and clinical phenotypes in patients with neurodevelopmental disorders. Our results suggest that clinical decision support algorithms that predict variant pathogenicity and function are feasible in the future.

Indexed as

Receptors, N-Methyl-D-AspartateSeizuresBiophysicsHumansPhenotypeVirulenceReceptors, N-Methyl-D-Aspartatebioinformaticsepilepsygeneticsion channelneurodevelopmental disorder

Identifiers

PMID36036558
PMCPMC9976975
OpenAlexW4293452398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.